Compare SYRE & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYRE | WMS |
|---|---|---|
| Founded | 2013 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.6B |
| IPO Year | 2015 | 2014 |
| Metric | SYRE | WMS |
|---|---|---|
| Price | $90.96 | $126.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 8 |
| Target Price | $85.08 | ★ $180.63 |
| AVG Volume (30 Days) | ★ 1.1M | 603.8K |
| Earning Date | 05-08-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.19 |
| Revenue | N/A | ★ $3,050,376,000.00 |
| Revenue This Year | N/A | $5.23 |
| Revenue Next Year | N/A | $12.79 |
| P/E Ratio | ★ N/A | $57.38 |
| Revenue Growth | N/A | ★ 5.03 |
| 52 Week Low | $14.51 | $124.75 |
| 52 Week High | $110.18 | $179.32 |
| Indicator | SYRE | WMS |
|---|---|---|
| Relative Strength Index (RSI) | 43.19 | 34.74 |
| Support Level | $82.83 | N/A |
| Resistance Level | $92.10 | $155.03 |
| Average True Range (ATR) | 3.85 | 3.52 |
| MACD | 0.24 | -0.58 |
| Stochastic Oscillator | 56.93 | 9.62 |
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.